ArticlePharmaceuticals (Basel, Switzerland)2022

Discovery of Azaindolin-2-One as a Dual Inhibitor of GSK3β and Tau Aggregation with Potential Neuroprotective Activity.

Taha F S Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.